glp-1 based therapeutics summit 2nd GLP-1-Based 2025 • Biopharma Asia Meet with ICON experts at

BM: Conceptualization, Data curation, Investigation, Methodology, Writing original draft, Writing review & editing

[DOI] [PubMed] [Google Scholar] [66].Watson E, Jonker DM, Jacobsen LV, Ingwersen SH, Population pharmacokinetics of liraglutide, a once-daily human glucagon-like peptide-1 analog, in healthy volunteers and subjects with type 2 diabetes, and comparison to twice-daily exenatide, Journal of clinical pharmacology, 50 (2010) 886894

If a prescription is appropriate, medication is ordered from a vetted partner pharmacy

GLP-1 is a medication used for weight loss, to treat type 2 diabetes and to reduce the risk of major adverse cardiovascular events

Orforglipron is an oral small-molecule GLP-1 agonist that could eventually provide GLP-1 level weight loss without injections, potentially making the oral advantage of Qsymia less relevant